The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis

Sadaf Ashraf(University of Nottingham), Cornelia H. de Moor(University of Nottingham)
Scientific Reports
March 18, 2019
10.1038/s41598-019-41140-1
Cited by 48

Related Papers

Specificity factors in cytoplasmic polyadenylation
|Wiley Interdisciplinary Reviews - RNA|2013|162
CAMKII as a therapeutic target for growth factor–induced retinal and choroidal neovascularization
|JCI Insight|2019|15
Cordycepin generally inhibits growth factor signal transduction in a systems pharmacology study
|FEBS Letters|2024|2